|
|
 | | | |
- close
- close
- close
- close
Abbott Lab (KAR:ABOT) |
QUOTE AND NEWS
PR Newswire
May 16
Comment
SHERMAN OAKS, Calif., May 16, 2012 /PRNewswire/ -- ABOT Mining (Pink Sheets: ABOT.pk) is pleased to provide the following corporate update that it has begun the process of updating its OTC reporting status directly through the OTC Disclosure and News
PR Newswire
May 10
Comment
SHERMAN OAKS, Calif., May 10, 2012 /PRNewswire/ -- ABOT Mining (Pink Sheets: ABOT.pk) is pleased to provide the following update on activities around its Aztlan 8 B Property in the province of Nayarit, Mexico in the highly mineralized area known as
Strategic Stocks and Penny Stocks
Jan 4
Comment
Strategic Stocks To Watch ABOT MINING CO (Other OTC: ABOT)
Abot Mining Corporation, an independent exploration company, engages in discovering, acquiring, developing, producing, and marketing precious and semi-precious metal properties. The...
Penny Sleuth
Dec 21
Comment
I cannot remember the last time a 3% rise in the S&P 500 was met with such indifference. We all know the drill by now: stocks slump for weeks, then offer what amounts to a glimmer of hope to investors — only to slowly eat away at the gains in...
Penny Stock DD
Dec 19
Comment
ABOT MINING CO IDA CAP (PINK:ABOT) penny stockheavily gained by 220% to close at $0.048 with overall traded volume of 161.02 million shares in the last trading session as compare to its average volume stood at 5.52 million. ABOT (penny stock)...
Forbes
Oct 20
Comment
This morning on the way to work I was reading in my Wall Street Journal about Abbott Lab's (ABT) decision to split itself in two creating a $22 billion (revs) growth- oriented medical products company that markets things like Similac, medicated...
The Economic Times
Jan 12
Comment
The purchase of Piramal Healthcare's domestic formulations biz by Abbott Lab has changed little on the ground for the foreign company even 3 mths after the acquisition, according to pharmacists distributing the company's products.
StreetInsider.com
Oct 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Abbott+Lab%27s+%28ABT%29+ARCHITECT+to+Run+Important+Rheumatoid+Arthritis+Diagnosis+Assay+/5029399.html for the full story.
Stock Blog Hub
Sep 22
Comment
Yesterday, Abbott (ABT) presented positive long-term data on the XIENCE V Everolimus Eluting Coronary Stent System from the pivotal SPIRIT III study conducted in the U.S.
Results showed that clinical advantages associated with the use of XIENCE...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
